Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency

Molecular Metabolism

Volumn 3, Issue 2, 2014, Pages 191-201

  Mokadem, Mohamad ^a   Zechner, Juliet F ^a   Margolskee, Robert F ^b   Drucker, Daniel J ^c   Aguirre, Vincent ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MONELL CHEMICAL SENSES CENTER   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Gut hormones; Mouse model; Taste perception; Weight loss surgery

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; FUNCTIONAL GLUCAGON LIKE PEPTIDE 1 DEFICIENCY; GLUCOSE HOMEOSTASIS; HORMONE DEFICIENCY; HORMONE RELEASE; LEAN BODY WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; THERAPY EFFECT; WEIGHT REDUCTION;

MUS;

EID: 84895794702     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.11.010     Document Type: Article

References (52)

1. Schauer P.R., Kashyap S.R., Wolski K., Brethauer S.A., Kirwan J.P., Pothier C.E., Thomas S., Abood B., Nissen S.E., Bhatt D.L. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New England Journal of Medicine 2012, 366:1567-1576.
2. Mingrone G., Panunzi S., De Gaetano A., Guidone C., Iaconelli A., Leccesi L., Nanni G., Pomp A., Castagneto M., Ghirlanda G., Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine 2012, 366:1577-1585.
3. Nguyen N.T., Masoomi H., Magno C.P., Nguyen X.M., Laugenour K., Lane J. Trends in use of bariatric surgery, 2003-2008. Journal of the American College of Surgeons 2011, 213:261-266.
4. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M.D., Pories W.J., Bantle J.P., Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine 2009, 122:248-256.
5. le Roux C.W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., Lonroth H., Fandriks L., Ghatei M.A., Bloom S.R., Olbers T. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Annals of Surgery 2007, 246:780-785.
6. Laferrere B., Teixeira J., McGinty J., Tran H., Egger J.R., Colarusso A., Kovack B., Bawa B., Koshy N., Lee H., Yapp K., Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2008, 93:2479-2485.
7. Salehi M., Prigeon R.L., D'Alessio D.A. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011, 60:2308-2314.
8. Jimenez A., Casamitjana R., Viaplana-Masclans J., Lacy A., Vidal J. GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care 2013, 36:2062-2069.
9. Jorgensen N.B., Dirksen C., Bojsen-Moller K.N., Jacobsen S.H., Worm D., Hansen D.L., Kristiansen V.B., Naver L., Madsbad S., Holst J.J. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes 2013, 62:3044-3052.
10. Shah M., Law J.H., Micheletto F., Sathananthan M., Man C.D., Cobelli C., Rizza R.A., Camilleri M., Zinsmeister A.R., Vella A. The contribution of endogenous glucagon-like peptide-1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes 2013, 10.2337/db13-0954.
11. Fenske W.K., Bueter M., Miras A.D., Ghatei M.A., Bloom S.R., le Roux C.W. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. International Journal of Obesity (London) 2012, 36:379-384.
12. Kindel T.L., Yoder S.M., Seeley R.J., D'Alessio D.A., Tso P. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. Journal of Gastrointestinal Surgery 2009, 13:1762-1772.
13. Gaitonde S., Kohli R., Seeley R. The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition. Journal of Surgical Research 2012, 178:33-39.
14. Chambers A.P., Jessen L., Ryan K.K., Sisley S., Wilson-Perez H.E., Stefater M.A., Gaitonde S.G., Sorrell J.E., Toure M., Berger J., D'Alessio D.A., Woods S.C., Seeley R.J., Sandoval D.A. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011, 141:950-958.
15. Troy S., Soty M., Ribeiro L., Laval L., Migrenne S., Fioramonti X., Pillot B., Fauveau V., Aubert R., Viollet B., Foretz M., Leclerc J., Duchampt A., Zitoun C., Thorens B., Magnan C., Mithieux G., Andreelli F. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metabolism 2008, 8:201-211.
16. Habegger K.M., Heppner K.M., Amburgy S.E., Ottaway N., Holland J., Raver C., Bartley E., Muller T.D., Pfluger P.T., Berger J., Toure M., Benoit S.C., Dimarchi R.D., Perez-Tilve D., D'Alessio D.A., Seeley R.J., Tschop M.H. GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes 2013, 10.2337/db13-0511.
17. Ayala J.E., Bracy D.P., James F.D., Julien B.M., Wasserman D.H., Drucker D.J. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology 2009, 150:1155-1164.
18. Drucker D.J. The role of gut hormones in glucose homeostasis. Journal of Clinical Investigation 2007, 117:24-32.
19. Campos R.V., Lee Y.C., Drucker D.J. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 1994, 134:2156-2164.
20. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
21. Tomas E., Wood J.A., Stanojevic V., Habener J.F. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice. Diabetes, Obesity and Metabolism 2011, 13:26-33.
22. Ip W., Shao W., Chiang Y.T., Jin T. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high fat diet fed mice. American Journal of Physiology- Endocrinology and Metabolism 2013, 10.1152/ajpendo.00376.2013.
23. Tomas E., Habener J.F. Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis. Trends in Endocrinology and Metabolism 2010, 21:59-67.
24. Young R.L. Sensing via intestinal sweet taste pathways. Frontiers in Neuroscience 2011, 5:23.
25. Jang H.J., Kokrashvili Z., Theodorakis M.J., Carlson O.D., Kim B.J., Zhou J., Kim H.H., Xu X., Chan S.L., Juhaszova M., Bernier M., Mosinger B., Margolskee R.F., Egan J.M. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:15069-15074.
26. Li Y., Kokrashvili Z., Mosinger B., Margolskee R.F. Gustducin couples fatty acid receptors to GLP-1 release in colon. American Journal of Physiology- Endocrinology and Metabolism 2013, 304:E651-E660.
27. Ruiz-Avila L., Wong G.T., Damak S., Margolskee R.F. Dominant loss of responsiveness to sweet and bitter compounds caused by a single mutation in alpha-gustducin. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:8868-8873.
28. Janssen S., Laermans J., Iwakura H., Tack J., Depoortere I. Sensing of fatty acids for octanoylation of ghrelin involves a gustatory G-protein. PLoS One 2012, 7:e40168.
29. Janssen S., Laermans J., Verhulst P.J., Thijs T., Tack J., Depoortere I. Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2094-2099.
30. Stefater M.A., Wilson-Perez H.E., Chambers A.P., Sandoval D.A., Seeley R.J. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocrine Reviews 2012, 33:595-622.
31. Dirksen C., Jorgensen N.B., Bojsen-Moller K.N., Jacobsen S.H., Hansen D.L., Worm D., Holst J.J., Madsbad S. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012, 55:1890-1901.
32. Scrocchi L.A., Brown T.J., MaClusky N., Brubaker P.L., Auerbach A.B., Joyner A.L., Drucker D.J. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nature Medicine 1996, 2:1254-1258.
33. Wong G.T., Gannon K.S., Margolskee R.F. Transduction of bitter and sweet taste by gustducin. Nature 1996, 381:796-800.
34. Zechner J.F., Mirshahi U.L., Satapati S., Berglund E.D., Rossi J., Scott M.M., Still C.D., Gerhard G.S., Burgess S.C., Mirshahi T., Aguirre V. Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology 2013, 144:580-590.
35. Ravussin Y., Gutman R., LeDuc C.A., Leibel R.L. Estimating energy expenditure in mice using an energy balance technique. International Journal of Obesity (London) 2013, 37:399-403.
36. Pullar J.D., Webster A.J. The energy cost of fat and protein deposition in the rat. British Journal of Nutrition 1977, 37:355-363.
37. Almeida N.G., Levitsky D.A., Strupp B. Enhanced thermogenesis during recovery from diet-induced weight gain in the rat. American Journal of Physiology 1996, 271:R1380-1387.
38. Mercer S.W., Trayhurn P. Effect of high fat diets on energy balance and thermogenesis in brown adipose tissue of lean and genetically obese ob/ob mice. Journal of Nutrition 1987, 117:2147-2153.
39. Eggert D.L., Nielsen M.K. Comparison of feed energy costs of maintenance, lean deposition, and fat deposition in three lines of mice selected for heat loss. Journal of Animal Science 2006, 84:276-282.
40. Lee S., Muniyappa R., Yan X., Chen H., Yue L.Q., Hong E.G., Kim J.K., Quon M.J. Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. American Journal of Physiology- Endocrinology and Metabolism 2008, 294:E261-E270.
41. Ali S., Lamont B.J., Charron M.J., Drucker D.J. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. Journal of Clinical Investigation 2011, 121:1917-1929.
42. Knauf C., Cani P.D., Perrin C., Iglesias M.A., Maury J.F., Bernard E., Benhamed F., Gremeaux T., Drucker D.J., Kahn C.R., Girard J., Tanti J.F., Delzenne N.M., Postic C., Burcelin R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. Journal of Clinical Investigation 2005, 115:3554-3563.
43. Sandoval D. CNS GLP-1 regulation of peripheral glucose homeostasis. Physiology and Behavior 2008, 94:670-674.
44. Yousseif A., Emmanuel J., Karra E., Millet Q., Elkalaawy M., Jenkinson A.D., Hashemi M., Adamo M., Finer N., Fiennes A.G., Withers D.J., Batterham R.L. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 Levels in non-diabetic humans. Obesity Surgery 2013, 10.1007/s11695-013-1066-0.
45. Saeidi N., Nestoridi E., Kucharczyk J., Uygun M.K., Yarmush M.L., Stylopoulos N. Sleeve gastrectomy and Roux-en-Y gastric bypass exhibit differential effects on food preferences, nutrient absorption and energy expenditure in obese rats. International Journal of Obesity 2012, 36:1396-1402.
46. Grayson B.E., Fitzgerald M.F., Hakala-Finch A.P., Ferris V.M., Begg D.P., Tong J., Woods S.C., Seeley R.J., Davidson T.L., Benoit S.C. Improvements in hippocampal-dependent memory and microglial infiltration with calorie restriction and gastric bypass surgery, but not with vertical sleeve gastrectomy. International Journal of Obesity (London) 2013, 10.1038/ijo.2013.100.
47. Scott W.R., Batterham R.L. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. American Journal of Physiology. Regulatory, Integrative and Comparative physiology 2011, 301:R15-R27.
48. Lingvay I., Guth E., Islam A., Livingston E. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery?. Diabetes Care 2013, 36:2741-2747.
49. Jackness C., Karmally W., Febres G., Conwell I.M., Ahmed L., Bessler M., McMahon D.J., Korner J. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients. Diabetes 2013, 62:3027-3032.
50. Isbell J.M., Tamboli R.A., Hansen E.N., Saliba J., Dunn J.P., Phillips S.E., Marks-Shulman P.A., Abumrad N.N. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010, 33:1438-1442.
51. Campos G.M., Rabl C., Peeva S., Ciovica R., Rao M., Schwarz J.M., Havel P., Schambelan M., Mulligan K. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. Journal of Gastrointestinal Surgery 2010, 14:15-23.
52. Sarwer D.B., Wadden T.A., Moore R.H., Baker A.W., Gibbons L.M., Raper S.E., Williams N.N. Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. Surgery for Obesity and Related Diseases 2008, 4:640-646.